Using tDCS as an Add-On Treatment Prior to FES Therapy in Improving Upper Limb Function in Severe Chronic Stroke Patients: A Randomized Controlled Study.

A preliminary analysis on baseline data (i.e., data before the baseline observation period) showed, cFMA scores [ t (28) = −0.585, p = 0.564], WMFT scores [ t (28) = −0.430, p = 0.668] and MAS scores [ t (28) = 0.786, p = 0.439] did not reach statistical significance between Group A and Group B (see Table 1 ).

also in 111,027 other papers